Share This

Public company info - TOT BIOPHARM International Company Limited , 01875.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

TOT BIOPHARM International Company Limited, 01875.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12
Net Cash Flow from Operating Activities 57,664 -176,106 -263,202 -250,805 -175,107 -117,590
Net Cash Flow from Return on Investments & Servicing of Finance -4,122 -1,031 86 -524 -1,725 202
　Interest Received 2,265 969 1,880 1,680 727 431
　Interest Paid -6,387 -2,000 -1,794 -2,204 -2,452 -229
　Dividend Received 0 0 0 0 0 0
　Dividend Paid 0 0 0 0 0 0
　Others 0 0 0 0 0 0
Taxes (Paid) / Refunded 0 0 0 0 0 0
Net Cash Flow from Investing Activities -282,764 -108,393 12,526 -51,102 -47,067 -110,957
　Additions to Fixed Assets -238,980 -112,283 -20,487 -36,286 -69,604 -111,908
　Disposal of Fixed Assets 1,875 18 358 19 0 0
　Increase in Investments -260,150 -1,500 -365,570 -131,800 -116,500 -60,300
　Decrease in Investments 215,634 8,402 399,919 118,019 147,631 84,026
　Net Cash Flow with Related Parties 409,164 0 0 0 0 0
　Others -410,307 -3,030 -1,694 -1,054 -8,594 -22,775
Net Cash Flow before Financing Activities -229,222 -285,530 -250,590 -302,431 -223,899 -228,345
Net Cash Flow from Financing Activities 487,627 214,082 -61,707 583,022 457,601 235,179
　New Loans 277,858 205,966 0 60,000 38,693 30,000
　Loans Repayment -198,200 -1,494 -61,707 -2,083 -68,967 -1,333
　Fixed Income/Debt Instruments 0 0 0 0 489,321 206,512
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0
　Equity Financing 0 1,990 0 525,105 0 0
　Net Cash Flow with Related Parties 409,164 0 0 0 0 0
　Others -1,195 7,620 0 0 -1,446 0
Increase(Decrease) in Cash & Cash Equivalents 258,405 -71,448 -312,297 280,591 233,702 6,834
Cash & Cash Equivalents at Beginning of Year 152,805 225,533 539,180 256,751 24,581 20,044
Net Cash Flow due to Change in Exchange Rate/Others 6,559 -1,280 -1,350 1,838 -1,532 -2,297
Cash & Cash Equivalents at End of Year 417,769 152,805 225,533 539,180 256,751 24,581
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.